- call +1-201-465-4211
- email sales@mrinsights.biz
Avalanche airbags are safety gear designed to prevent the wearer from being buried while skiing and mountaineering. In an avalanche, larger objects rise to the surface, while smaller objects sink to the bottom. An airbag system incorporated into a backpack, with a large balloon or balloons that inflates at the pull of a cord, is designed to make the person wearing it larger so that they naturally rise to the surface of the snow.
With the rising popularity of ski touring and freeriding many manufacturers notice that there is a need for more protection while being in the freedom of backcountry or high alpine. So nowadays, avalanche airbag backpack became a usual piece of equipment next to your regular avalanche safety equipment: avalanche beacon, probe, and shovel. And thanks to a high demand for this piece of equipment, avalanche airbag backpacks are no longer considered a luxury good but are getting more and more affordable each season. But avalanche airbag packs are only helpful in critical situations of avalanche slides, they in no way guarantee survival and they are not meant to be used as the only mean of protection, and uncertainties related to survival percentages is limiting growth for the Avalanche Airbags market.
Direct-to-consumer is the most lucrative sales channel for avalanche airbags. Consumer familiarity, and availability of a wide range remain the key USPs of this sales channel. Specialty stores follow suit. These two sales channels collectively account for nearly two-third of all avalanche airbags sold globally.
According to this study, over the next five years the Regenerative Medicine market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 260 million by 2024, from US$ 190 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Regenerative Medicine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.
This study considers the Regenerative Medicine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Mono Avalanche Airbags
Dual Avalanche Airbags
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Skiing
Climbing
Hiking
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ABS Protection GmbH
Mammut
Clarus Corporation
Backcountry Access
Scott
Ortovox
ARVA
Osprey Packs
The North Face
Dakine
Mystery Ranch
Millet(Calida Group)
Motorfist
Deuter
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Regenerative Medicine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Regenerative Medicine market by identifying its various subsegments.
Focuses on the key global Regenerative Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Regenerative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Regenerative Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Regenerative Medicine Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Regenerative Medicine Consumption 2014-2024
2.1.2 Regenerative Medicine Consumption CAGR by Region
2.2 Regenerative Medicine Segment by Type
2.2.1 Mono Avalanche Airbags
2.2.2 Dual Avalanche Airbags
2.3 Regenerative Medicine Consumption by Type
2.3.1 Global Regenerative Medicine Consumption Market Share by Type (2014-2019)
2.3.2 Global Regenerative Medicine Revenue and Market Share by Type (2014-2019)
2.3.3 Global Regenerative Medicine Sale Price by Type (2014-2019)
2.4 Regenerative Medicine Segment by Application
2.4.1 Skiing
2.4.2 Climbing
2.4.3 Hiking
2.4.4 Others
2.5 Regenerative Medicine Consumption by Application
2.5.1 Global Regenerative Medicine Consumption Market Share by Application (2014-2019)
2.5.2 Global Regenerative Medicine Value and Market Share by Application (2014-2019)
2.5.3 Global Regenerative Medicine Sale Price by Application (2014-2019)
3 Global Regenerative Medicine by Players
3.1 Global Regenerative Medicine Sales Market Share by Players
3.1.1 Global Regenerative Medicine Sales by Players (2017-2019)
3.1.2 Global Regenerative Medicine Sales Market Share by Players (2017-2019)
3.2 Global Regenerative Medicine Revenue Market Share by Players
3.2.1 Global Regenerative Medicine Revenue by Players (2017-2019)
3.2.2 Global Regenerative Medicine Revenue Market Share by Players (2017-2019)
3.3 Global Regenerative Medicine Sale Price by Players
3.4 Global Regenerative Medicine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Regenerative Medicine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Regenerative Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Regenerative Medicine by Regions
4.1 Regenerative Medicine by Regions
4.1.1 Global Regenerative Medicine Consumption by Regions
4.1.2 Global Regenerative Medicine Value by Regions
4.2 Americas Regenerative Medicine Consumption Growth
4.3 APAC Regenerative Medicine Consumption Growth
4.4 Europe Regenerative Medicine Consumption Growth
4.5 Middle East & Africa Regenerative Medicine Consumption Growth
5 Americas
5.1 Americas Regenerative Medicine Consumption by Countries
5.1.1 Americas Regenerative Medicine Consumption by Countries (2014-2019)
5.1.2 Americas Regenerative Medicine Value by Countries (2014-2019)
5.2 Americas Regenerative Medicine Consumption by Type
5.3 Americas Regenerative Medicine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Regenerative Medicine Consumption by Countries
6.1.1 APAC Regenerative Medicine Consumption by Countries (2014-2019)
6.1.2 APAC Regenerative Medicine Value by Countries (2014-2019)
6.2 APAC Regenerative Medicine Consumption by Type
6.3 APAC Regenerative Medicine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Regenerative Medicine by Countries
7.1.1 Europe Regenerative Medicine Consumption by Countries (2014-2019)
7.1.2 Europe Regenerative Medicine Value by Countries (2014-2019)
7.2 Europe Regenerative Medicine Consumption by Type
7.3 Europe Regenerative Medicine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Regenerative Medicine by Countries
8.1.1 Middle East & Africa Regenerative Medicine Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Regenerative Medicine Value by Countries (2014-2019)
8.2 Middle East & Africa Regenerative Medicine Consumption by Type
8.3 Middle East & Africa Regenerative Medicine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Regenerative Medicine Distributors
10.3 Regenerative Medicine Customer
11 Global Regenerative Medicine Market Forecast
11.1 Global Regenerative Medicine Consumption Forecast (2019-2024)
11.2 Global Regenerative Medicine Forecast by Regions
11.2.1 Global Regenerative Medicine Forecast by Regions (2019-2024)
11.2.2 Global Regenerative Medicine Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Regenerative Medicine Forecast by Type
11.8 Global Regenerative Medicine Forecast by Application
12 Key Players Analysis
12.1 ABS Protection GmbH
12.1.1 Company Details
12.1.2 Regenerative Medicine Product Offered
12.1.3 ABS Protection GmbH Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 ABS Protection GmbH News
12.2 Mammut
12.2.1 Company Details
12.2.2 Regenerative Medicine Product Offered
12.2.3 Mammut Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Mammut News
12.3 Clarus Corporation
12.3.1 Company Details
12.3.2 Regenerative Medicine Product Offered
12.3.3 Clarus Corporation Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Clarus Corporation News
12.4 Backcountry Access
12.4.1 Company Details
12.4.2 Regenerative Medicine Product Offered
12.4.3 Backcountry Access Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Backcountry Access News
12.5 Scott
12.5.1 Company Details
12.5.2 Regenerative Medicine Product Offered
12.5.3 Scott Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Scott News
12.6 Ortovox
12.6.1 Company Details
12.6.2 Regenerative Medicine Product Offered
12.6.3 Ortovox Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Ortovox News
12.7 ARVA
12.7.1 Company Details
12.7.2 Regenerative Medicine Product Offered
12.7.3 ARVA Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 ARVA News
12.8 Osprey Packs
12.8.1 Company Details
12.8.2 Regenerative Medicine Product Offered
12.8.3 Osprey Packs Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Osprey Packs News
12.9 The North Face
12.9.1 Company Details
12.9.2 Regenerative Medicine Product Offered
12.9.3 The North Face Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 The North Face News
12.10 Dakine
12.10.1 Company Details
12.10.2 Regenerative Medicine Product Offered
12.10.3 Dakine Regenerative Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Dakine News
12.11 Mystery Ranch
12.12 Millet(Calida Group)
12.13 Motorfist
12.14 Deuter
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Regenerative Medicine
Table Product Specifications of Regenerative Medicine
Figure Regenerative Medicine Report Years Considered
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
